A

Alkermes plc
D

ALKS

26.120
USD
-0.41
(-1.55%)
Market Closed
Volume
74,651
EPS
1
Div Yield
-
P/E
12
Market Cap
4,307,221,564
Related Instruments
ABBV
ABBV
-0.465
(-0.24%)
190.325 USD
AZN
AZN
-1.055
(-1.43%)
72.640 USD
BMY
BMY
-0.525
(-1.07%)
48.455 USD
GILD
GILD
3.000
(2.65%)
116.210 USD
JNJ
JNJ
-1.240
(-0.73%)
168.350 USD
LLY
LLY
8.95
(1.11%)
812.95 USD
MRK
MRK
0.570
(0.68%)
84.730 USD
NVS
NVS
0.260
(0.22%)
117.680 USD
PFE
PFE
-0.555
(-2.19%)
24.810 USD
SNY
SNY
0.230
(0.46%)
50.370 USD
TEVA
TEVA
0.195
(1.19%)
16.545 USD
More
News

Title: Alkermes plc

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.